Web Analytics

3 Latest Announced Rounds

  • $1,643,411
    Pre-Seed

    3 Investors

    Biotechnology Research
    May 13th, 2026
  • $21,000,000
    Series A

    3 Investors

    Software Development
    May 13th, 2026
  • $4,200,000
    Seed

    5 Investors

    Desktop Computing Software Products
    May 13th, 2026
$1,382.68M Raised in 43 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Noxilizer, Inc.

start up
United States - Hanover, Maryland
  • 11/09/2025
  • Unknown
  • $30,000,000

Noxilizer, Inc. provides ultra-low temperature (10°C to 30°C) nitrogen dioxide sterilization technology that offers many benefits over traditional sterilization methods. Noxilizer sells sterilization equipment to pharmaceutical, biotech and medical device manufacturers and also offers contract sterilization services at its Baltimore, MD facilities. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process.

To learn more about Noxilizer’s contract sterilization services or sterilization equipment please email info@noxilizer.com or visit www.noxilizer.com


Related People

Christopher ThatcherFounder

Christopher Thatcher United States - Hanover, Maryland

A Senior Life Sciences Executive experienced as a Board Member, CEO and Divisional President in the commercialization of Class I, II, and III medical devices, for public or privately owned companies, with capital equipment, disposables, implantable or service agreements utilized in the operating room or office based, domestically and internationally, in enterprises ranging from $20M to $425M in annual revenues, converting debt, venture funding or Initial Public Offering proceeds into successful turnarounds by accelerate revenue growth, margin expansion, operating leverage and ultimately EBITDA for their respective enterprises.